New In Vitro Diagnostic (IVD) Technology Developments Highlighted at BIOMEDevice San Jose 2018

Industry leaders to provide insight on IVD trends, growth and products

New York, New York, UNITED STATES

SANTA MONICA, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- BIOMEDevice San Jose 2018, Silicon Valley’s leading event for medical technology professionals, today announced that it will feature premier educational content focused on the growing In Vitro Diagnostic (IVD) industry. Through thoughtfully curated sessions and panels, speakers from leading companies will explore trends and forecast how IVD is expected to grow in the near future. Returning for its eleventh year on December 5 – 6, 2018, BIOMEDevice San Jose will feature more than 250 leading medtech organizations and more than 1,500 medical device industry professionals. To apply for a media pass to attend, please visit:

The North American IVD market is expected to grow from $31.1 billion in 2017 to $36.9 billion in 2022, according to a study by BBC Research. The San Francisco Bay Area is home to well-established IVD device leaders responsible for spearheading industry advancements including Bio-Rad, Roche and Thermo Fisher and many other promising startups breaking into the market. To foster growth and knowledge sharing, BIOMEDevice San Jose will bring leading experts to Silicon Valley for exclusive panels and sessions at this key time for the IVD industry for those looking to expand domestically and abroad.

“Testing is required for most clinical decisions and IVD vendors to innovate at a fast pace, to help improve survival rates, reduce hospital stays, and lower costs,” said Bruce Carlson, Publisher, Kalorama Information. “Each year only increases the awareness that healthcare providers, payors, and investors have of the importance of in vitro diagnostics, and the important contribution they make in fighting cancer, treating anti-microbial resistance, and even opioid abuse.  It’s a 65 billion-dollar industry, but that belies the true value—IVD is influencing the 18 trillion dollar world healthcare market.” 

BIOMEDevice San Jose will host a dedicated-area for presentations, Center Stage, which will feature conference-level presentations on the most notable trends across the IVD industry from leading organizations such as Aromyx, CDxPrecision Health and Kalorama Information. 

“At CDx Precision Health, we are seeing first-hand the positive impact that IVD services and products are having on improving the quality of people’s lives,” said Alan K. Hauser, Strategic Business Development SVP, CDx Precision Health. “Collaboration with top minds in such a pivotal moment for the industry will lead to stronger processes and developments for the medical device community as a whole.”

Notable IVD-focused presentations at BIOMEDevice San Jose 2018 include:

The IVD Market Opportunity: Fast-Growth Markets, New Products, Disruptive Trends
Presented by: Bruce Carlson, Publisher, Kalorama Information
December 5, 2018 at 10:30 a.m. – 11:00 a.m.

  • In the session, attendees will learn the many factors causing an increase in the rise of IVD services to monitor health, which in turn is fueling IVD market growth. Additionally, Carlson will speak to trends such as technology advancements, rising end-user awareness, and miniaturization driving demand for point-of-care products.

Panel: Your Next Move in the IVD Space: Is Merging, Mixing, Matching in IVD Still the Rule?  Moderated by: Alan “AK” Houser, Strategic Business Development SVP, CDx Precision Health
December 6, 2018 at 2:00 p.m. – 2:45 p.m.

  • Representatives from Aromyx, Two Pore Guys, and Satch Med Consulting will discuss the current IVD marketplace and what to expect from next-gen IVD companies. The discussion will provide real-world advice on methods for evaluating new IVD technologies such as gene sequencing and gene editing.

“In vitro diagnostics is experiencing undeniable growth nationally, due to the increasing demand for advanced diagnostic techniques. This year, BIOMEDevice San Jose will feature the industry’s most esteemed leaders who will share their expertise on navigating this growth and leveraging improved IVD processes and trends,” said Amy Sklar, Group Senior Vice President, UBM. “Attendees can expect to see the latest IVD products and will have the opportunity to speak to the top manufacturers in the market today.”

To learn more about the content at BIOMEDevice San Jose, please visit: 

Connect with BIOMEDevice San Jose: #BIOMEDevice

Media Contacts:
Lauren Lloyd,, (310) 266-4792

Rich Trunzo,, (424) 316-7169

About Advanced Manufacturing Expos & Conferences:
UBM's Advanced Manufacturing portfolio is the leading B-to-B event producer, publisher, and digital media business for the world's $3 trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the advanced manufacturing market and leverage our proprietary 1.3 million name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Advanced Manufacturing portfolio is organized by UBM, which in June 2018 combined with Informa PLC to become a leading B2B information services group and the largest B2B Events organizer in the world. To learn more and for the latest news and information, visit and